Randall Moreadith
Chief Development Officer Serina Therapeutics
Seminars
Tuesday 7th April 2026
Novel Lipid Nanoparticles Entirely Built on a POZ Platform
9:00 am
- Overcoming the PEG dilemma with PEOZ-lipids in lipid nanoparticle formulations
- Design and synthesis of novel ionizable Poly (2-Oxazoline) (POZ) lipids to replace current ionizable lipids
- Developing POZ-based lipid nanoparticles for the delivery of a multitude of oligonucleotide payloads
